4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults (ENS@T-CANCER)
Date du début: 1 janv. 2011, Date de fin: 30 juin 2016,
Among patients with adrenal masses Adrenocortical carcinoma (ACC) and malignant pheochromocytomas (MPH) are found with a low incidence but very unfavorable prognosis. Due to this poor clinical outcome, concomitant hormone dysregulation and limited treatment options the two cancer entities severely impact on affected patients. However, the rarity of the tumors also impedes clinical studies which ar ...
Voir le projet
17
Participants partenaires
TERMINÉ
EVALUATING THE IMPACT OF STRUCTURAL POLICIES ON HEALTH INEQUALITIES AND THEIR SOCIAL DETERMINANTS AND FOSTERING CHANGE (SOPHIE)
Date du début: 1 nov. 2011, Date de fin: 31 oct. 2015,
The need to deal with health inequalities is now on the agenda of key supranational institutions, such as the European Commission (EC). To tackle the so-called “causes of the causes of health inequity”, the focus should be put on structural policies, policies that – especially in the current times of financial and employment crisis – influence patterns of social stratification, living and working ...
Voir le projet
14
Participants partenaires
TERMINÉ
Developing methodologies to reduce inequalities in the determinants of health (DEMETRIQ)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2014,
RationaleSocial inequalities in health are a major challenge to public health in Europe and hence a priority topic for the EU. While the average level of health in EU countries has continued to improve over the last decades, differences in health between advantaged and disadvantaged sections of the population within each country remain substantial. A broad spectrum of policies influences the deter ...
Voir le projet
10
Participants partenaires
TERMINÉ
European Consortium for Anticancer Antibody Development (EUCAAD)
Date du début: 1 mai 2008, Date de fin: 30 avr. 2012,
Cancer is the second leading cause of death in European countries, and one of the most imminent health problems in the developed world. Innovative, so-called targeted therapies are urgently needed that aim specifically at cancer cells or to cells of the stroma that support tumor growth. The ultimate goal of a targeted therapy is to increase anti-tumor efficacy with lowest possible side effects. R ...
Voir le projet